Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

12.12.16	Scottish Medicines Consortium Approves Sanofi Prostate Cancer Drug (PR Newswire)
08.12.16	NWBO To Leave Nasdaq, Voyager Cruises Ahead, Watch Out For REGN (RTTNews)
08.12.16	Regeneron, Sanofi: EMA Accepts Dupixent Marketing Application For Review (RTTNews)
06.12.16	Bloomberg : Sanofi To Explore Counterbid For Actelion Amid J&J Talks (RTTNews)
22.11.16	ACOR Fails To Walk The Talk, SNY Gets FDA Nod, New Use For Genmab's Old Drug (RTTNews)
22.11.16	Sanofi Gets FDA Approval Of Soliqua 100/33 To Treat Adults With Type 2 Diabetes (RTTNews)
22.11.16	Sanofi Receives FDA Approval of Soliqua(TM) 100/33, for the Treatment of Adults with Type 2 Diabetes (GlobeNewswire)
18.11.16	Global Survey into Perceptions of Men’s Health Reveals British Men Are Not Reaping Benefits of Local Health Services and Information (PR Newswire)
18.11.16	BSTC Finds New Use For Old Drug, FHCO Gets A Boost, SUPN Put On Notice (RTTNews)
17.11.16	Sanofi and Regeneron Announce Praluent® (alirocumab) Cardiovascular Outcomes Trial will Continue as Planned Following Interim Analysis (GlobeNewswire)
16.11.16	Sanofi and Regeneron Present Results from Phase 3 MONARCH Study of Investigational Sarilumab at American College of Rheumatology Annual Meeting (GlobeNewswire)
14.11.16	Alnylam : Sanofi Genzyme Opt-in Decision For Co-Commercialization Of Fitusiran (RTTNews)
11.11.16	Sanofi Reports CHMP Recommendation For Suliqua - Quick Facts (RTTNews)
11.11.16	Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU (GlobeNewswire)
10.11.16	MannKind And Sanofi Enter Into Agreement On AFREZZ (RTTNews)
31.10.16	BIIB To Face FDA, It's A Thumb Down For REGN, STJ Meets Trial Goal (RTTNews)
28.10.16	Sanofi Lifts FY16 View As Q3 Profit Up; Plans EUR3.5 Bln Stock Buyback; Stock Up (RTTNews)
28.10.16	Sanofi Lifts FY16 Business EPS Guidance, Q3 Profit Up (RTTNews)
27.10.16	Sanofi Pasteur, Fiocruz And WRAIR To Collaborate On Zika Vaccine Research (RTTNews)
27.10.16	Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research (GlobeNewswire)
12.10.16	Sanofi Expects $100 Mln Charge In Q3 On Cipro Generic Litigation (RTTNews)
12.10.16	Sanofi: Availability of the Pre-quarterly Results Communication (GlobeNewswire)
05.10.16	Eli Lilly Unit To Buy BIVI's U.S. Feline, Canine And Rabies Vaccines Portfo (RTTNews)
02.10.16	Regeneron, Sanofi: Dupixent Phase 3 Atopic Dermatitis Studies Meet Primary Goal (RTTNews)
26.09.16	Sanofi : BARDA Grants $43.2 Million USD To Sanofi Pasteur For Zika (RTTNews)
26.09.16	Sanofi : BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika (GlobeNewswire)
26.09.16	Regeneron, Sanofi: FDA Accepts Dupilumab BLA For Priority Review - Quick Facts (RTTNews)
26.09.16	Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA (GlobeNewswire)
22.09.16	Evotec Enters Research Collaboration With Inserm Transfert - Quick Facts (RTTNews)
19.09.16	Sanofi Files Suit In U.S. To Defend Patent Rights On Lantus, Lantus Solostar (RTTNews)
19.09.16	Sanofi Files Suit in U.S. to Defend Paten Rights on Lantus® and Lantus® Solostar® (GlobeNewswire)
16.09.16	Sanofi Announces Positive Data From Study Of Lemtrada In Patients With RRMS (RTTNews)
16.09.16	Sanofi: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme's Lemtrada® (alemtuzumab) in Clinical Trials (GlobeNewswire)
13.09.16	Sanofi's Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone (GlobeNewswire)
12.09.16	Sanofi, Verily Life Sciences Launch JV For Comprehensive Diabetes Care (RTTNews)
12.09.16	Sanofi, Verily Life Launch JV To Develop Diabetes Management Platform (RTTNews)
12.09.16	Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform (GlobeNewswire)
06.09.16	Sanofi successfully prices EUR 3 billion bond issue (GlobeNewswire)
29.08.16	Regeneron, Sanofi Report Positive Data For Praluent - Quick Facts (RTTNews)
29.08.16	Sanofi and Regeneron Present Positive Phase 3 Investigational Data for Praluent® (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016 (GlobeNewswire)
22.08.16	Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation (RTTNews)
22.08.16	PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move (RTTNews)
19.08.16	Sanofi Provides Update on New Drug Application for Investigational Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide (GlobeNewswire)
14.08.16	Sanofi Reports Dengue Immunization Public Program In Paraná State Of Brazil (RTTNews)
13.08.16	Sanofi: Dengue Immunization Public Program in Paraná State of Brazil Set To Achieve WHO 2020 Ambition (GlobeNewswire)
01.08.16	Sanofi: EMA To Review Marketing Authorisation Application For Sarilumab (RTTNews)
29.07.16	Sanofi Q2 Profit Declines On Weak Sales; Maintains FY16 Outlook - Quick Facts (RTTNews)
28.07.16	FDA Approves Sanofi's Adlyxin For Treatment Of Adults With Type 2 Diabetes (RTTNews)
28.07.16	Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes (GlobeNewswire)
08.07.16	Sanofi: Availability of the Pre-quarterly Results Communication (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

18:01		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
18:01		Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester
18:01		NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit grünem Vorzeichen
17:58		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
17:58		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
17:58		Handel in Frankfurt: TecDAX letztendlich in Grün
17:58		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

18:01

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

18:01

Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester

18:01

NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit grünem Vorzeichen

17:58

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

17:58

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

17:58

Handel in Frankfurt: TecDAX letztendlich in Grün